Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study
NCT00116090
·
clinicaltrials.gov ↗
COMPLETED
Status
6300
Enrollment
NIH
Sponsor class
Conditions
Uveitis
Cancer
Infection
Mortality
Immunosuppression
Sponsor
National Eye Institute (NEI)